These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9128855)

  • 21. Dopamine transporter binding in rat striatum and nucleus accumbens is unaltered following chronic changes in dopamine levels.
    Moody CA; Granneman JG; Bannon MJ
    Neurosci Lett; 1996 Oct; 217(1):55-7. PubMed ID: 8905738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.
    Vaughan RA; Huff RA; Uhl GR; Kuhar MJ
    J Biol Chem; 1997 Jun; 272(24):15541-6. PubMed ID: 9182590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity.
    Fricks-Gleason AN; German CL; Hoonakker AJ; Friend DM; Ganesh KK; Carver AS; Hanson GR; Fleckenstein AE; Keefe KA
    Synapse; 2016 Apr; 70(4):139-46. PubMed ID: 26799527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model of the sodium dependence of dopamine uptake in rat striatal synaptosomes.
    Wheeler DD; Edwards AM; Chapman BM; Ondo JG
    Neurochem Res; 1993 Aug; 18(8):927-36. PubMed ID: 8371835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
    Willett MC; Dluzen DE
    Brain Res; 2004 Dec; 1029(2):186-94. PubMed ID: 15542073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synaptosomal dopamine uptake in rat striatum following controlled cortical impact.
    Wilson MS; Chen X; Ma X; Ren D; Wagner AK; Reynolds IJ; Dixon CE
    J Neurosci Res; 2005 Apr; 80(1):85-91. PubMed ID: 15704194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free radical production induced by methamphetamine in rat striatal synaptosomes.
    Pubill D; Chipana C; Camins A; Pallàs M; Camarasa J; Escubedo E
    Toxicol Appl Pharmacol; 2005 Apr; 204(1):57-68. PubMed ID: 15781294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine.
    Berman SB; Zigmond MJ; Hastings TG
    J Neurochem; 1996 Aug; 67(2):593-600. PubMed ID: 8764584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function.
    Maragos WF; Young KL; Turchan JT; Guseva M; Pauly JR; Nath A; Cass WA
    J Neurochem; 2002 Nov; 83(4):955-63. PubMed ID: 12421368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum.
    Nakayama M; Koyama T; Yamashita I
    Brain Res; 1993 Jan; 601(1-2):209-12. PubMed ID: 8431767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Origin of 4-hydroxynonenal incubation-induced inhibition of dopamine transporter and Na+/K+ adenosine triphosphate in rat striatal synaptosomes.
    Fleuranceau-Morel P; Barrier L; Fauconneau B; Piriou A; Huguet F
    Neurosci Lett; 1999 Dec; 277(2):91-4. PubMed ID: 10624817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron deficiency alters dopamine transporter functioning in rat striatum.
    Erikson KM; Jones BC; Beard JL
    J Nutr; 2000 Nov; 130(11):2831-7. PubMed ID: 11053528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter.
    Matsubara K; Senda T; Uezono T; Fukushima S; Ohta S; Igarashi K; Naoi M; Yamashita Y; Ohtaki K; Hayase N; Akutsu S; Kimura K
    Eur J Pharmacol; 1998 May; 348(1):77-84. PubMed ID: 9650834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methamphetamine self-administration acutely decreases monoaminergic transporter function.
    McFadden LM; Stout KA; Vieira-Brock PL; Allen SC; Nielsen SM; Wilkins DG; Hanson GR; Fleckenstein AE
    Synapse; 2012 Mar; 66(3):240-5. PubMed ID: 22120988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors.
    Ugarte YV; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2003 Jul; 472(3):165-71. PubMed ID: 12871750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transporters.
    Haughey HM; Brown JM; Wilkins DG; Hanson GR; Fleckenstein AE
    Brain Res; 2000 Apr; 863(1-2):59-65. PubMed ID: 10773193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies.
    Hirata H; Cadet JL
    J Neurochem; 1997 Aug; 69(2):780-90. PubMed ID: 9231739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.